|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.71%
|
US
|
NASDAQ
|
|
AGEN
|
Agenus Inc.
|
0.71%
|
US
|
NASDAQ
|
|
KZR
|
Kezar Life Sciences, Inc.
|
0.71%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
0.68%
|
US
|
NASDAQ
|
|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
AMRS
|
Amyris, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.64%
|
US
|
NASDAQ
|
|
MRSN
|
Mersana Therapeutics, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
CMPS
|
COMPASS Pathways Plc
|
0.61%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.61%
|
US
|
NASDAQ
|